|
|
| | Anhydro Abiraterone Basic information |
| Product Name: | Anhydro Abiraterone | | Synonyms: | Abiraterone Acetate IMP;Anhydro Abiraterone;Abiraterone Anhydro Impurity;Anhydro Abiraterone/17-(Pyridin-3-yl)androsta-3,5,16-triene;3-((8R,9S,10R,13S,14S)-10,13-dimethyl;17-(Pyridin-3-yl)androsta-3,5,16-triene;Pyridine, 3-androsta-3,5,16-trien-17-yl-;Abiraterone ImpurityABCDEFGHI | | CAS: | 154229-20-6 | | MF: | C24H29N | | MW: | 331.49 | | EINECS: | | | Product Categories: | | | Mol File: | 154229-20-6.mol |  |
| | Anhydro Abiraterone Chemical Properties |
| Melting point | 118 - 122°C | | Boiling point | 475.0±45.0 °C(Predicted) | | density | 1.10±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | Chloroform (Slightly), Methanol (Slightly) | | pka | 5.31±0.12(Predicted) | | form | Solid | | color | Off-White to Pale Beige |
| | Anhydro Abiraterone Usage And Synthesis |
| Uses | Anhydro Abiraterone is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| | Anhydro Abiraterone Preparation Products And Raw materials |
|